Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,602
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Sinovac Biotech, Ltd. market cap is $460.27M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sinovac Biotech, Ltd. 52 week high is $6.47 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sinovac Biotech, Ltd. 52 week low is $6.47 as of November 22, 2026.
Sinovac Biotech, Ltd. stock price today is $6.47.
Sinovac Biotech, Ltd. stock price yesterday was $6.49.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Sinovac Biotech, Ltd.'s P/E ratio is -4.73.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Sinovac Biotech, Ltd. P/B ratio is 0.1032.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Sinovac Biotech, Ltd. 50-day moving average is $6.47.